Treatment Information

Back

Ovarian Cancer treatment details. Chemotherapy.

University General Hospital of Heraklion, Crete, Greece.

Survival: monthsCountry:Greece
Toxiciy Grade:4City/State/Province:Crete
Treatments:ChemotherapyHospital:University General Hospital of Heraklion
Drugs:Journal:Link
Date:Apr 2014

Description:

Patients:
This phase 2 study involved 23 advanced, platinum-sensitive, recurrent ovarian cancer patients who had been previously treated. The median patient age was 62.0 years.

Treatment:
Patients received chemotherapy with docetaxel and pegylated liposomal doxorubicin (PLD).

Toxicities:
The most severe toxicities were of grade 4 and included neutropenia and diarrhea. Grade 3 hand-foot skin reaction was also reported.

Results:
The median overall survival was 18.8 months.

Correspondence: Dr. Vassilis Georgoulias; email: [email protected]



Back